Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
about
Targeted therapies and the treatment of non-clear cell renal cell carcinomaIndirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period.Advanced kidney cancer: treating the elderly.Efficacy of targeted therapy for advanced renal cell carcinoma: a systematic review and meta-analysis of randomized controlled trials.Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size.
P2860
Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@ast
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@en
type
label
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@ast
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@en
prefLabel
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@ast
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@en
P2093
P1476
Renal cell carcinoma: assessme ...... the National Cancer Data Base.
@en
P2093
Andrew Stewart
Gladell P Paner
Jamie Ritchey
Mahul B Amin
Nalan Nese
P356
10.1016/J.ANNDIAGPATH.2008.10.002
P50
P577
2008-12-12T00:00:00Z